1. Home
  2. BNR vs VBIX Comparison

BNR vs VBIX Comparison

Compare BNR & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNR
  • VBIX
  • Stock Information
  • Founded
  • BNR 2014
  • VBIX N/A
  • Country
  • BNR China
  • VBIX Israel
  • Employees
  • BNR N/A
  • VBIX N/A
  • Industry
  • BNR Medical Specialities
  • VBIX Computer Software: Prepackaged Software
  • Sector
  • BNR Health Care
  • VBIX Technology
  • Exchange
  • BNR Nasdaq
  • VBIX Nasdaq
  • Market Cap
  • BNR 29.1M
  • VBIX 26.4M
  • IPO Year
  • BNR 2020
  • VBIX N/A
  • Fundamental
  • Price
  • BNR $3.70
  • VBIX $4.70
  • Analyst Decision
  • BNR
  • VBIX
  • Analyst Count
  • BNR 0
  • VBIX 0
  • Target Price
  • BNR N/A
  • VBIX N/A
  • AVG Volume (30 Days)
  • BNR 36.5K
  • VBIX 114.5K
  • Earning Date
  • BNR 08-21-2025
  • VBIX 08-14-2025
  • Dividend Yield
  • BNR N/A
  • VBIX N/A
  • EPS Growth
  • BNR N/A
  • VBIX N/A
  • EPS
  • BNR N/A
  • VBIX N/A
  • Revenue
  • BNR $72,112,038.00
  • VBIX $19,672,000.00
  • Revenue This Year
  • BNR $136.32
  • VBIX N/A
  • Revenue Next Year
  • BNR N/A
  • VBIX N/A
  • P/E Ratio
  • BNR N/A
  • VBIX N/A
  • Revenue Growth
  • BNR 0.53
  • VBIX N/A
  • 52 Week Low
  • BNR $2.18
  • VBIX $0.18
  • 52 Week High
  • BNR $7.90
  • VBIX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • BNR 59.32
  • VBIX N/A
  • Support Level
  • BNR $3.06
  • VBIX N/A
  • Resistance Level
  • BNR $3.50
  • VBIX N/A
  • Average True Range (ATR)
  • BNR 0.25
  • VBIX 0.00
  • MACD
  • BNR 0.01
  • VBIX 0.00
  • Stochastic Oscillator
  • BNR 69.57
  • VBIX 0.00

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

Share on Social Networks: